According to recent industry analysis, the global GLP-1 market was valued at approximately USD 53.5 billion in 2024 and is projected to reach between USD 268 billion and USD 880 billion by 2034
Diabetes Strong Mounjaro vs Ozempic: How do they compare
[11] Lactation: Caution is urged in breastfeeding mothers (see Pregnancy section)
The economics of GLP-1s have undergone several heavy-duty studies and overviews, including one in October 2024 by the U.S
Pharmaceuticals companies may be affected by industry competition, dependency on a limited number of products, obsolescence of products, government approvals and regulations, loss or impairment of intellectual property rights and litigation regarding product liability
The medication is a glucagon-like peptide-1 (GLP-1) receptor agonist which means it's sensitive to temperature changes